Cumberland Pharmaceuticals, Inc. (NASDAQ:CPIX) had a loss and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. The revenue miss is a negative sign to shareholders seeking high growth out of the company. Shares are down 2.45%.
Cumberland Pharmaceuticals, Inc. Earnings Cheat Sheet
Results: Adjusted Earnings Per Share decreased to $-0.03 in the quarter versus EPS of $0.09 in the year-earlier quarter.
Revenue: Decreased 42.6% to $7.1 million from the year-earlier quarter.
Actual vs. Wall St. Expectations: Cumberland Pharmaceuticals, Inc. reported adjusted EPS loss of $0.03 per share. By that measure, the company missed the mean analyst estimate of $0.02. It missed the average revenue estimate of $9.4 million.
Quoting Management: “We made considerable progress this quarter by completing our pediatric program for Caldolor, obtaining FDA approval for new Acetadote labeling and further expanding our network of international partners,” said A.J. Kazimi, Chief Executive Officer of Cumberland Pharmaceuticals. “We are fortunate to have a strong balance sheet through this transition period as we manage Acetadote’s life cycle and work to add new products to our portfolio.”
Key Stats (on next page)…
Revenue decreased 30.8% from $10.26 million in the previous quarter. EPS decreased to $-0.03 in the quarter versus EPS of $0.05 in the previous quarter.
Looking Forward: Analysts have a neutral outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings is a profit of $0.03 and has not changed. For the current year, the average estimate has moved up from a profit of $0.13 to a profit of $0.14 over the last ninety days.
Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)